Integer’s Alden, N.Y. Location Breaks Ground on Building Expansion
Integer Holdings Corporation (NYSE: ITGR) has announced a significant expansion at its Alden, NY facility to increase production capacity for Xcellion® Lithium Ion rechargeable batteries. The expansion, which began in December 2020, aims to enhance battery production for applications in neuromodulation and cochlear devices. The project includes new manufacturing equipment and facility upgrades, expected to complete in 2021. This strategic investment is designed to meet the growing demands of Integer's cardiac and neuromodulation customers.
- Expansion of production capacity for Xcellion® Lithium Ion batteries, increasing supply for medical devices.
- Strategic investment to support growth in neuromodulation and cochlear application markets.
- None.
~ Expansion to Significantly Increase Plant’s Production Capacity of Xcellion® Lithium Ion Rechargeable Batteries ~
PLANO, Texas, Jan. 14, 2021 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device outsource (MDO) manufacturer, today announced that its Alden, N.Y., facility recently broke ground on an expansion to accommodate new equipment that will substantially increase the plant’s production capacity of rechargeable Xcellion® Lithium Ion batteries. With more than 50 years experience, Integer is a worldwide leader in the design, development and manufacture of custom implantable batteries.
“Integer continues to make strategic investments to advance our state-of-the-art battery technology and increase capacity to support our customers’ needs,” said Joel Becker, president of Integer’s Cardiac Rhythm Management and Neuromodulation business. “This expansion will increase battery cell production capacity related to neuromodulation and cochlear applications.”
The project kicked off in mid-December 2020 and will add both production equipment and a build-out of Integer’s existing facility. The building expansion is projected to be completed in 2021 and will be followed by the installation and qualification of new, state-of-the-art manufacturing equipment.
The Xcellion® Lithium Ion rechargeable batteries produced in Alden power implantable pulse generators (IPGs) and other medical devices for use by Integer’s cardiac & neuromodulation customers. These devices deliver therapies such as spinal cord stimulation, deep brain stimulation and left ventricular assist device treatments, as well as power external sound processing units for cochlear applications.
About Integer®
Integer Holdings Corporation (NYSE: ITGR) is one of the largest medical device outsource (MDO) manufacturers in the world serving the cardiac, neuromodulation, vascular, portable medical, advanced surgical and orthopedics markets. The company provides innovative, high-quality medical technologies that enhance the lives of patients worldwide. In addition, it develops batteries for high-end niche applications in energy, military, and environmental markets. Greatbatch Medical®, Lake Region Medical® and Electrochem® comprise the company’s brands. Additional information is available at www.integer.net.
Forward-Looking Statements
Some of the statements contained in this press release are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including the statements relating to our expectation of continued compliance with covenants and the benefits of the amendment. You can identify forward-looking statements by terminology such as “may,” “will,” “should,” “could,” “expects,” “intends,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential” or “continue” or variations or the negative of these terms or other comparable terminology.
These statements are only predictions and actual events or results may differ materially from those stated or implied by these forward-looking statements. In evaluating these statements, you should carefully consider a number of factors, including, but not limited to, risks and uncertainties that arise from time to time and are described in Item 1A “Risk Factors” of our Annual Report on Form 10-K and in our other periodic filings with the SEC. Except as may be required by law, we assume no obligation to update forward-looking statements in this press release, whether to reflect changed assumptions, the occurrence of unanticipated events or changes in future operating results, financial conditions or prospects, or otherwise.
Investor Relations
Tony Borowicz
tony.borowicz@integer.net
716.759.5809
Media Relations
Kelly Butler
kelly.butler@integer.net
214.618.4216
FAQ
What is the purpose of the expansion at Integer's Alden facility?
When did Integer start the expansion project?
When is the completion date for the facility expansion?
What products are powered by the Xcellion<sup>®</sup> Lithium Ion batteries?
